ISPC
iSpecimen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.91
−0.75%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.93
From 52W high−97.35%
Volume507635.00
Market cap$2.29M
P/E (TTM)—
P/S (TTM)4.9x
Div yield—
Key dataOct 19, 2026
Open
$0.93
From 52W high
−97.35%
Volume
507635.00
Market cap
$2.29M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
P/E (TTM)
—
RSI (14)
23.5
MomentumView details →
1D Return
−0.75%
YTD Return
−91.20%
SummaryUpdated Jun 1, 2026
iSpecimen Inc. (NASDAQ:ISPC) is a biotechnology services company founded in 2009 and headquartered in Lexington, Massachusetts. The company went public in June 2021 through an initial public offering. iSpecimen operates as a technology-enabled marketplace that connects life science researchers with healthcare organizations that have access to human biological specimens needed for medical research and drug development.
Similar companies
Latest newsMore news →
iSpecimen is supporting a hospital laboratory's validation of a new chemistry analyzer by coordinating the collection of more than 1,700 human specimens.21d agoiSpecimen Inc. agreed to acquire certain artificial intelligence software, models, source code, data rights, and intellectual property from Foldlab AI Ltd. for an aggregate purchase price of $4,500,000, consisting of $2,000,000 in cash and $2,500,000 in shares of common stock, subject to stockholder and Nasdaq approval.45d ago